Eliquis and Plendil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Eliquis (apixaban) and Plendil (felodipine). Common drug interactions include faeces hard among females and metastases to spine among males.

The phase IV clinical study analyzes what interactions people have when they take Eliquis and Plendil. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Eliquis?

Eliquis has active ingredients of apixaban. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 191,864 Eliquis users. Check the latest studies of Eliquis.

What is Plendil?

Plendil has active ingredients of felodipine. It is often used in high blood pressure. eHealthMe is studying from 4,990 Plendil users. Check the latest studies of Plendil.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 03, 2026

11 people who take Eliquis and Plendil together, and have interactions are studied.

Eliquis and Plendil drug interactions.

What are the common drug interactions of Eliquis and Plendil, by gender? *:

female:

  1. Faeces hard
  2. Therapeutic response unexpected
  3. Diarrhoea
  4. Dizziness
  5. Dysstasia (difficulty in standing)
  6. Muscular weakness (muscle weakness)
  7. Visual acuity reduced (reduced clearness of vision)

male:

  1. Metastases to spine (cancer spreads to spine)
  2. Prostatic specific antigen increased
  3. Terminal state (the transitional states between life and biological death)
  4. Aortic aneurysm (enlargement of an aortic artery caused by a weakening of the artery wall)
  5. Back pain
  6. Circulatory collapse
  7. Dyspnoea (difficult or laboured respiration)
  8. Iliac artery stenosis (the abnormal narrowing of a iliac artery)
  9. Metastases to bone (cancer spreads to bone)
  10. Metastases to liver (cancer spreads to liver)

What are the common drug interactions of Eliquis and Plendil, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Faeces hard
  2. Therapeutic response unexpected
  3. Circulatory collapse
  4. Dyspnoea (difficult or laboured respiration)
  5. Iliac artery stenosis (the abnormal narrowing of a iliac artery)
  6. Metastases to bone (cancer spreads to bone)
  7. Metastases to liver (cancer spreads to liver)
  8. Staphylococcal bacteraemia (a bacterial infection of blood)
  9. Terminal state (the transitional states between life and biological death)
  10. Visual acuity reduced (reduced clearness of vision)

What are the existing conditions these people have? *

  1. Barrett's Oesophagus (barrett's oesophagus is a disorder in which the lining of the oesophagus (the tube that carries food from the throat to the stomach) is damaged by stomach acid and changed to a lining similar to that of the stomach): 6 people, 54.55%
  2. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 2 people, 18.18%
  3. Prostate Cancer: 2 people, 18.18%
  4. Gastric Disorder (disease of stomach): 1 person, 9.09%
  5. Fluid Retention (an abnormal accumulation of fluid in the blood): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Eliquis and Plendil?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Eliquis and Plendil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Eliquis:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Plendil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Eliquis and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Plendil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on apixaban and felodipine (the active ingredients of Eliquis and Plendil, respectively), and Eliquis and Plendil (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: